Brown Rice and Fatty Liver: Evidence and Diet Tips

Brown rice and fatty liver disease are increasingly discussed together as interest in dietary approaches to liver health grows. Fatty liver disease, particularly metabolic dysfunction-associated steatotic liver disease (MASLD), affects a significant proportion of UK adults and is closely linked to diet, insulin resistance, and lifestyle. Replacing refined carbohydrates such as white rice with whole grains like brown rice may support liver health by reducing glycaemic load and improving fibre intake. This article explores the evidence behind brown rice for fatty liver, how it compares to white rice, and what broader dietary and lifestyle changes are recommended by NHS and NICE guidance.

What is fatty liver disease and how common is it in the UK?

Fatty liver disease, most commonly MASLD (previously NAFLD), is one of the UK's most prevalent chronic liver conditions, strongly associated with obesity, type 2 diabetes, and insulin resistance, and often undetected until found incidentally.

Fatty liver disease is one of the most prevalent chronic liver conditions in the UK, with the British Liver Trust estimating that it affects a substantial proportion of the adult population. The most common form is metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD).^[5][3] Many NHS and NICE resources still use the term NAFLD, so readers searching for information may encounter both names. MASLD occurs when excess fat accumulates in liver cells in the absence of significant alcohol consumption. A separate but related condition, alcohol-related liver disease (ALD), is driven by heavy or prolonged alcohol use.

MASLD exists on a spectrum. At its mildest, it involves simple fat accumulation (steatosis) with little or no inflammation. In a proportion of people, this progresses to metabolic dysfunction-associated steatohepatitis (MASH), which involves liver inflammation and cell damage, and can eventually lead to fibrosis, cirrhosis, or liver failure. NICE guidance (NG49) highlights that MASLD is strongly associated with obesity, type 2 diabetes, high blood pressure, and raised blood lipids.^[1][2]

Many people with fatty liver disease have no symptoms in the early stages. Importantly, liver blood tests and routine imaging can appear normal even when the condition is present, which means it often goes undetected until identified incidentally. Risk factors include a sedentary lifestyle, a diet high in refined carbohydrates and saturated fats, and insulin resistance.

If MASLD is suspected, NICE guidance (NG49 and DG34) recommends that GPs use the FIB-4 score (a calculation based on age, liver enzyme levels, and platelet count, with age-adjusted thresholds) as an initial assessment of fibrosis risk. Those with an indeterminate or high FIB-4 score may be referred for second-line testing such as the enhanced liver fibrosis (ELF) test or transient elastography (FibroScan).^[1][4] People with suspected advanced fibrosis are referred to hepatology for further assessment.

Seek urgent medical attention if you develop any of the following symptoms, which may indicate serious liver disease: yellowing of the skin or whites of the eyes (jaundice), new or worsening swelling of the abdomen (ascites), vomiting blood or passing black tarry stools, confusion or difficulty thinking clearly, or severe abdominal pain. These symptoms require prompt assessment and you should contact your GP urgently or call 999 or attend an emergency department if symptoms are severe.

Can eating brown rice help improve a fatty liver?

Brown rice may support liver health as part of a balanced diet due to its lower glycaemic index and higher fibre content, but no single food can reverse fatty liver disease and broader lifestyle changes remain essential.

Replacing refined carbohydrates with whole grains such as brown rice may support liver health as part of a balanced dietary pattern, though brown rice alone is not a treatment for fatty liver disease. Brown rice is a whole grain, meaning it retains its bran and germ layers, which are removed during the milling of white rice. These layers contain dietary fibre, B vitamins, magnesium, and phytochemicals that may influence metabolic processes relevant to liver fat accumulation.

The primary mechanism through which brown rice may benefit liver health is its lower glycaemic index (GI) compared to white rice. Foods with a lower GI cause a more gradual rise in blood glucose and insulin levels. Because insulin resistance and hyperinsulinaemia are closely linked to hepatic fat deposition, choosing lower-GI carbohydrates may help reduce the metabolic drivers of MASLD. The fibre content of brown rice also supports gut health and may modestly improve lipid profiles. GI values vary by rice variety and cooking method, and the figures cited in the next section should be understood as approximate ranges rather than fixed values.

It is important to note that no single food can reverse fatty liver disease. The NHS and NICE both emphasise that MASLD management centres on sustained lifestyle change, including overall dietary quality, physical activity, and, where appropriate, weight reduction. Brown rice can be a useful component of a liver-friendly diet, but it should be considered alongside broader dietary improvements, such as those outlined in the NHS Eatwell Guide, rather than as a standalone remedy. Pairing brown rice with vegetables, legumes, or a source of protein also helps moderate the overall glycaemic response of a meal. If you have been diagnosed with fatty liver disease, your GP or a registered dietitian (HCPC-registered) can provide personalised dietary guidance.

How does brown rice compare to white rice for liver health?

Brown rice has a lower glycaemic index (approximately 50 to 55 versus 64 to 72 for white rice) and nearly four times more dietary fibre, making it a more liver-friendly carbohydrate choice for people with MASLD.

Brown rice has a meaningfully lower glycaemic index than white rice, which is the key nutritional distinction relevant to liver health. White rice is a refined grain: the milling process strips away the bran and germ, leaving primarily starch. This results in a food that is digested and absorbed rapidly, producing a sharper postprandial glucose and insulin response. According to the University of Sydney GI Database, brown rice has a GI of approximately 50 to 55, compared to around 64 to 72 for white rice, though these values vary depending on cooking method, rice variety, and preparation, and should be treated as indicative ranges.

Beyond glycaemic response, brown rice provides significantly more dietary fibre than white rice. UK food composition data (McCance and Widdowson, CoFID) indicate that cooked brown rice contains approximately 1.8 g of fibre per 100 g, compared to around 0.4 g for cooked white rice. Brown rice also provides higher levels of magnesium, phosphorus, and phytochemical compounds including ferulic acid and gamma-oryzanol. Laboratory and animal studies suggest these compounds may have anti-inflammatory and hepatoprotective properties; however, robust human clinical trial data specifically in people with MASLD remain limited, and these findings should be regarded as preliminary rather than established clinical benefits.

Cooking method affects the GI of both rice types: longer cooking times and higher water absorption tend to increase GI by breaking down starch structure further, so avoiding overcooking is a reasonable practical step, though the magnitude of this effect varies.

From a practical standpoint, the difference in caloric content between brown and white rice is modest, so the benefit of switching lies primarily in the improved nutrient profile and lower glycaemic impact rather than calorie reduction. For people managing fatty liver disease, choosing brown rice over white rice is a reasonable, evidence-informed swap, but portion size and overall dietary context, including what the rice is served with, remain equally important considerations.

What does the evidence say about diet and fatty liver disease?

A Mediterranean-style dietary pattern has the strongest evidence for improving fatty liver disease, with whole grain intake associated with lower liver fat; reducing added sugars and ultra-processed foods is also widely recommended.

The strongest dietary evidence for improving fatty liver disease supports a Mediterranean-style eating pattern, which naturally incorporates whole grains, vegetables, legumes, oily fish, and healthy fats such as olive oil, while limiting red meat, refined carbohydrates, and added sugars. NICE guidance (NG49) recommends dietary modification as a first-line intervention, with an emphasis on reducing overall caloric intake where weight loss is indicated.^[1][2] The EASL-EASD-EASO 2024 Clinical Practice Guidelines for MASLD similarly endorse a Mediterranean dietary pattern as the most evidence-supported approach.^[6]

Regarding whole grains specifically, observational studies have associated higher whole grain intake with lower liver fat content and reduced markers of liver inflammation. A 2021 review published in the journal Nutrients (Della Pepa et al.) found that whole grain consumption was inversely associated with MASLD risk, with proposed mechanisms including improved insulin sensitivity, reduced hepatic lipogenesis, and beneficial effects on the gut microbiome. However, most studies in this area are observational, meaning causality cannot be firmly established, and further randomised controlled trial evidence is needed.

Fructose and added sugars, particularly from sugar-sweetened beverages, have the most consistent evidence linking them to increased hepatic fat accumulation, and reducing these is widely recommended. Conversely, diets high in ultra-processed foods and refined starches, including white rice consumed in large quantities, are associated with poorer metabolic outcomes. The overall quality and pattern of the diet appears more important than any single food.

For people seeking to manage fatty liver disease through diet, consulting a GP or a registered dietitian (HCPC-registered) is advisable. A structured dietary assessment can identify specific areas for improvement and ensure that any changes are safe and sustainable alongside any existing medical conditions or medications.

What other foods and lifestyle changes support a healthy liver?

Oily fish, vegetables, legumes, coffee, and olive oil are associated with liver health benefits, while weight reduction of 5 to 10%, regular physical activity, and limiting alcohol are among the most evidence-supported lifestyle changes for MASLD.

A range of dietary and lifestyle measures, beyond any single food choice, are supported by evidence for improving liver health in people with MASLD. The following are among the most consistently recommended:

Foods that may support liver health:

• Oily fish (salmon, mackerel, sardines): rich in omega-3 fatty acids; meta-analyses (including reviews published in Clinical Nutrition and Hepatology) suggest omega-3 supplementation can reduce hepatic triglyceride levels in people with MASLD, though effects on fibrosis are less established^[8][9]

• Vegetables and legumes: high in fibre and antioxidants, supporting gut health and reducing inflammation

• Coffee: observational studies and meta-analyses (including analyses published in the BMJ and Alimentary Pharmacology and Therapeutics) have associated moderate coffee consumption with lower rates of liver fibrosis and cirrhosis; the mechanism is not fully established and this is not a clinical recommendation to increase coffee intake^[10][11]

• Nuts and seeds: sources of healthy unsaturated fats and vitamin E; note that vitamin E supplementation has been studied in MASH management but NICE (NG49) restricts its consideration to specific cases, such as biopsy-confirmed steatohepatitis, under clinician supervision.^[1][13] Self-supplementation with vitamin E is not advised without medical guidance

• Olive oil: a key component of the Mediterranean diet, associated with improved insulin sensitivity

Lifestyle changes with strong evidence:

• Weight reduction: NICE (NG49) states that losing 5 to 10% of body weight is associated with meaningful reductions in liver fat, and losses of 10% or more may improve fibrosis in some people^[1][2]

• Regular physical activity: both aerobic exercise and resistance training independently reduce hepatic fat, even without significant weight loss, per NICE NG49

• Alcohol reduction or abstinence: the UK Chief Medical Officers' low-risk drinking guidelines recommend no more than 14 units per week for adults, spread across three or more days, with no completely safe level. For people with ALD or advanced liver disease, abstinence is generally required; your GP can advise on what is appropriate for your situation

• Avoiding ultra-processed foods and added sugars: particularly fructose-containing drinks

Bolt Pharmacy is a GPhC-registered UK online pharmacy. Weight management consultations with prescriber review and pharmacist support are available, which may be relevant for people whose fatty liver disease is linked to excess weight; any prescription medicine would only be provided where clinically appropriate following a consultation. Sustainable lifestyle change remains the cornerstone of MASLD management, and your GP can refer you to specialist dietetic or hepatology services if needed.

Scientific References

1. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49).
2. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49) — full guideline PDF.
3. Non-alcoholic fatty liver disease (NAFLD).
4. NAFLD: transient elastography, ARFI, and ELF test — final scope (HTG655).
5. Global epidemiological patterns and disease burden of metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and alcohol-associated liver disease, and alcohol-associated liver disease.
6. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
7. Composition of Foods Integrated Dataset (CoFID) — McCance and Widdowson.
8. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis (Parker HM et al.).
9. Omega-3 polyunsaturated fatty acids and nonalcoholic fatty liver disease in adults: a meta-analysis of randomized controlled trials.
10. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.
11. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.
12. The effect of coffee consumption on non-alcoholic fatty liver disease and liver fibrosis: a meta-analysis of 11 epidemiological studies.
13. Metabolic dysfunction-associated steatotic liver disease (MASLD): recommendations for research (NG49).
14. Alcohol consumption: advice on low risk drinking — UK Chief Medical Officers' guidelines.
15. Delivering Better Oral Health — Chapter 12: Alcohol.

Frequently Asked Questions